GlassScriptPhysician profile
Francisco Chacon
NPI 1376701144
$716.37
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $111 · 2021: $606.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $138.44 | 2020-2021 | |
| Lilly USA, LLC | $90.93 | 2021 | |
| Novo Nordisk INC | $85.10 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $76.69 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $71.86 | 2020-2021 | |
| Biohaven Pharmaceuticals, INC. | $37.99 | 2021 | |
| Mylan Specialty L.P. | $34.52 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.29 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $27.60 | 2021 | |
| Janssen Pharmaceuticals, INC | $23.45 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $21.07 | 2021 | |
| Alexion Pharmaceuticals, INC. | $18.57 | 2021 | |
| Esperion Therapeutics, INC. | $17.47 | 2021 | |
| Amgen INC. | $15.74 | 2021 | |
| Sunovion Pharmaceuticals INC. | $14.51 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $12.14 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francisco Chacon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.